Thompson Siegel & Walmsley’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,070
| Closed | -$97K | – | 559 |
|
|
2022
Q3 | $97K | Buy |
10,070
+854
| +9% | +$8.23K | ﹤0.01% | 390 |
|
|
2022
Q2 | $67K | Sell |
9,216
-696,440
| -99% | -$5.06M | ﹤0.01% | 400 |
|
|
2022
Q1 | $9.11M | Buy |
705,656
+147,193
| +26% | +$1.9M | 0.13% | 163 |
|
|
2021
Q4 | $8.91M | Sell |
558,463
-43,908
| -7% | -$701K | 0.12% | 160 |
|
|
2021
Q3 | $9.68M | Sell |
602,371
-207,042
| -26% | -$3.33M | 0.14% | 148 |
|
|
2021
Q2 | $11.2M | Buy |
809,413
+144,850
| +22% | +$2M | 0.15% | 131 |
|
|
2021
Q1 | $9.71M | Buy |
664,563
+152,710
| +30% | +$2.23M | 0.14% | 138 |
|
|
2020
Q4 | $8.9M | Buy |
511,853
+137,168
| +37% | +$2.38M | 0.14% | 140 |
|
|
2020
Q3 | $6.87M | Sell |
374,685
-58,532
| -14% | -$1.07M | 0.13% | 142 |
|
|
2020
Q2 | $7.74M | Buy |
+433,217
| New | +$7.74M | 0.16% | 127 |
|